MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
MIST
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines... Show more

A.I. Advisor
published Earnings

MIST is expected to report earnings to fall 16.25% to -16 cents per share on November 12

Milestone Pharmaceuticals MIST Stock Earnings Reports
Q3'25
Est.
$-0.17
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.11
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.02
The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -18 cents. With 791.24K shares outstanding, the current market capitalization sits at 152.99M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
MIST
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For MIST
(Try 14 days for Free)
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MIST showed earnings on August 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading
A.I. Advisor
published General Information

General Information

a developer and manufacturer of cardiovascular medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
1111 Dr. Frederik-Philips Boulevard
Phone
+1 514 336-0444
Employees
47
Web
https://www.milestonepharma.com